Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs SoundHound AI Inc (SOUN) Price & Performance

Heron Therapeutics IncTrade
SoundHound AI IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs SoundHound AI Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while SoundHound AI Inc trades at $6.45 (market cap $2.75B). The key difference: SoundHound AI Inc is far larger — about 30.1× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.

HRTXSOUN
Market Cap
$91.46M$2.75B
Sector
HealthTechnology
52-Week High
$1.96$21.40
52-Week Low
$0.39$5.90
Enterprise Value
$189.36M$2.54B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

SoundHound AI Inc

SoundHound AI (SOUN) trades at $6.31, down 37% year-to-date amid concerns over persistent losses and cash burn despite 52% revenue growth in 2025. The stock shows a bearish technical trend with neutral oscillators, while fundamentals reveal a negative net income margin of -91.84% and high valuation multiples. Recent positive developments include being named a Leader in Gartner's Magic Quadrant for Conversational AI Platforms (GlobeNewsWire, July 13, 2026) and beating EPS estimates in three consecutive quarters.

The outlook remains speculative with significant upside potential based on a $13.00 analyst consensus price target, but high execution risks and cash burn pose threats. Investment opportunity hinges on the company's ability to monetize its AI platform expansion and achieve profitability, while risks include competitive pressures and reliance on financing to cover operational losses.

Returns comparison

Trailing returns across standard periods

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About SoundHound AI Inc

SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.

Read more on SOUN